TITLE

Estimated intermediate risk endometrial cancer: debate and new perspectives on therapy individualization and prognosis establishment starting from a peculiar case

AUTHOR(S)
Gizzo, Salvatore; Fabris, Alberta; Litta, Pietro; Saccardi, Carlo
PUB. DATE
May 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 5, p2664
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
96450854

 

Related Articles

  • Contemporary Clinical Management of Endometrial Cancer. Dinkelspiel, Helen E.; Wright, Jason D.; Lewin, Sharyn N.; Herzog, Thomas J. // Obstetrics & Gynecology International;2013, p1 

    Although the contemporary management of endometrial cancer is straightforward in many ways, novel data has emerged over the past decade that has altered the clinical standards of care while generating new controversies that will require further investigation. Fortunately most cases are diagnosed...

  • Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries. Jones, Michael E.; van Leeuwen, Flora E.; Hoogendoorn, Wilhelmina E.; Mourits, Marian J. E.; Hollema, Harry; van Boven, Hester; Press, Michael F.; Bernstein, Leslie; Swerdlow, Anthony J. // Breast Cancer Research;2012, Vol. 14 Issue 3, p1 

    Introduction: Tamoxifen is an effective treatment for breast cancer but an undesirable side-effect is an increased risk of endometrial cancer, particularly rare tumor types associated with poor prognosis. We investigated whether tamoxifen therapy increases mortality among breast cancer patients...

  • Risk Factors for Node Affectation and Recurrence in Endometrial Cancer. Alonso, Sonsoles; Lapuente, Fernando; González-Martin, Antonio; Chiva, Luis // Current Women's Health Reviews;Nov2011, Vol. 7 Issue 4, p320 

    Endometrial cancer is the most common gynecologic malignancy in western countries. In United States, 42000 estimated new cases were diagnosed in 2009, approximately 7780 women died from this cancer last year. This malignancy has a five year survival rate around 80%, thanks to its early...

  • Controversies in the Management of Endometrial Carcinoma. Ying Zhang; Jian Wang // Obstetrics & Gynecology International;2010, Vol. 2010, p1 

    Endometrial carcinoma is the most common type of female genital tract malignancy. Although endometrial carcinoma is a low grade curable malignancy, the condition of the disease can range from excellent prognosis with high curability to aggressive disease with poor outcome. During the last 10...

  • Predictions of cancer incidence in Poland in 2019. Wojtyś, Piotr; Godlewski, Dariusz; Antczak, Andrzej // Central European Journal of Medicine;Apr2013, Vol. 8 Issue 2, p185 

    Introduction: The future burden of cancer can be quantify from two different perspectives: the number of new cancer cases and age-standardized rates. Goal: Making prognosis of number of cancer cases in Poland in 2019. Methodology: These predictions of number of cancer cases in 2019 has been...

  • ImportanÅ£a testelor imunohistochimice în diagnosticul pozitiv al leziunilor epiteliale preneoplazice È™i neoplazice endometriale. Comănescu, Maria; Potecă, Anca Gabriela; Comănescu, Alexandru; Potecă, Teodor; Mitran, Mihai // Ginecologia.ro;sep2015, Vol. 3 Issue 9, p46 

    Endometrial malignant neoplasms are one of the most common lesions of the female reproductive tract, new cases being described each year. Both precursor endometrial lesions and endometrial malignant neoplasms are associated with numerous risk factors such as obesity, diabetes, hypertension and...

  • Invited Commentary: Endometrial Hyperplasia--Getting Back to Normal.  // American Journal of Epidemiology;Sep2008, Vol. 168 Issue 6, p571 

    Cancer precursors can help to reveal clues about how and when risk factors influence the development of carcinoma. Endometrial carcinoma is well-suited to studies of precursors: Strong risk and protective factors exist, as does a good candidate precursor lesion, called atypical endometrial...

  • Tamoxifen continues to worry researchers.  // Nutrition Health Review: The Consumer's Medical Journal;1994, Issue 70, p14 

    Reports that researchers at King's College School of Medicine in London have established a link between tamoxifen therapy for breast cancer and increased risk of endometrial cancer.

  • Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Moore, S. C.; Gierach, G. L.; Schatzkin, A.; Matthews, C. E. // British Journal of Cancer;9/28/2010, Vol. 103 Issue 7, p933 

    Physical activity has been hypothesised to reduce endometrial cancer risk, but this relationship has been difficult to confirm because of a limited number of prospective studies. However, recent publications from five cohort studies, which together comprise 2663 out of 3463 cases in the...

  • The Adverse Effects of Hormone Replacement Therapy. Tavani, A.; La Vecchia, C. // Drugs & Aging;1999, Vol. 14 Issue 5, p347 

    This article reviews epidemiological data on potential adverse effects of hormone replacement therapy (HRT) on the risk of breast, endometrial and ovarian cancer, on the risk of stroke, and on the risk of venous and pulmonary thromboembolism. As for the potential adverse effects on cancer risk,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics